Prostate Cancer
Risk Stratification of Low-Risk Prostate Cancer: Individualizing Care in the Era of Active Surveillance.
April 14, 2023
Identifying Men Who Can Remain on Active Surveillance Despite Biopsy Reclassification to Grade Group 2 Prostate Cancer.
April 14, 2023
A DNA copy number alteration classifier as a prognostic tool for prostate cancer patients.
April 13, 2023
Targeting advanced prostate cancer with STEAP1 chimeric antigen receptor T cell and tumor-localized IL-12 immunotherapy.
April 13, 2023
Unknown Causes of Death in Cancer Patients.
April 13, 2023
ETV4 mediates dosage-dependent prostate tumor initiation and cooperates with p53 loss to generate prostate cancer.
April 13, 2023
Landscape of prostate-specific membrane antigen heterogeneity and regulation in AR-positive and AR-negative metastatic prostate cancer.
April 12, 2023
Disparities in access to robotic technology and perioperative outcomes among patients treated with radical prostatectomy.
April 12, 2023
External beam radiotherapy combination is a risk factor for bladder cancer in patients with prostate cancer treated with brachytherapy.
April 12, 2023
Diagnostic and cost-effectiveness of axial skeleton MRI in staging high-risk prostate cancer.
April 12, 2023